Prostaglandins and leukotrienes: Advances in eicosanoid biology

被引:2927
作者
Funk, CD [1 ]
机构
[1] Univ Penn, Ctr Expt Therapeut, Philadelphia, PA 19104 USA
[2] Univ Penn, Dept Pharmacol, Philadelphia, PA 19104 USA
关键词
D O I
10.1126/science.294.5548.1871
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Prostaglandins and leukotrienes are potent eicosanoid lipid mediators derived from phospholipase-released arachidonic acid that are involved in numerous homeostatic biological functions and inflammation. They are generated by cyclooxygenase isozymes and 5-lipoxygenase, respectively, and their biosynthesis and actions are blocked by clinically relevant nonsteroidal anti-inflammatory drugs, the newer generation coxibs (selective inhibitors of cyclooxygenase-2), and Leukotriene modifiers. The prime mode of prostaglandin and Leukotriene action is through specific G protein-coupled receptors, many of which have been cloned recently, thus enabling specific receptor agonist and antagonist development Important insights into the mechanisms of inflammatory responses, pain, and fever have been gleaned from our current understanding of eicosanoid biology.
引用
收藏
页码:1871 / 1875
页数:5
相关论文
共 64 条
  • [1] Insight into prostaglandin, leukotriene, and other eicosanoid functions using mice with targeted gene disruptions
    Austin, SC
    Funk, CD
    [J]. PROSTAGLANDINS & OTHER LIPID MEDIATORS, 1999, 58 (5-6) : 231 - 252
  • [2] Immunology - Telling the brain about pain
    Bartfai, T
    [J]. NATURE, 2001, 410 (6827) : 425 - 427
  • [3] ENZYMATIC FORMATION OF PROSTAGLANDIN E2 FROM ARACHIDONIC ACID PROSTAGLANDINS + RELATED FACTORS 32
    BERGSTROM, S
    DANIELSSON, H
    SAMUELSSON, B
    [J]. BIOCHIMICA ET BIOPHYSICA ACTA, 1964, 90 (01) : 207 - &
  • [4] Nuclear localization of prostaglandin E2 receptors
    Bhattacharya, M
    Peri, KG
    Almazan, G
    Ribeiro-Da-Silva, A
    Shichi, H
    Durocher, Y
    Abramovitz, M
    Hou, X
    Varma, DR
    Chemtob, S
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (26) : 15792 - 15797
  • [5] NSAIDS and selective COX-2 inhibitors: competition between gastroprotection and cardioprotection
    Boers, M
    [J]. LANCET, 2001, 357 (9264) : 1222 - 1223
  • [6] Arachidonic acid is preferentially metabolized by cyclooxygenase-2 to prostacyclin and prostaglandin E2
    Brock, TG
    McNish, RW
    Peters-Golden, M
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1999, 274 (17) : 11660 - 11666
  • [7] Burr GO, 1930, J BIOL CHEM, V86, P0587
  • [8] The N-terminal "β-barrel" domain of 5-lipoxygenase is essential for nuclear membrane translocation
    Chen, XS
    Funk, CD
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (01) : 811 - 818
  • [9] The PPAR alpha-leukotriene B-4 pathway to inflammation control
    Devchand, PR
    Keller, H
    Peters, JM
    Vazquez, M
    Gonzalez, FJ
    Wahli, W
    [J]. NATURE, 1996, 384 (6604) : 39 - 43
  • [10] Pharmacogenetic association between ALOX5 promoter genotype and the response to anti-asthma treatment
    Drazen, JM
    Yandava, CN
    Dubé, L
    Szczerback, N
    Hippensteel, R
    Pillari, A
    Israel, E
    Schork, N
    Silverman, ES
    Katz, DA
    Drajesk, J
    [J]. NATURE GENETICS, 1999, 22 (02) : 168 - 170